Logo image of BLN.CA

BLACKLINE SAFETY CORP (BLN.CA) Stock Fundamental Analysis

TSX:BLN - Toronto Stock Exchange - CA0923821007 - Common Stock - Currency: CAD

7.11  -0.03 (-0.42%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BLN. BLN was compared to 13 industry peers in the Electronic Equipment, Instruments & Components industry. While BLN seems to be doing ok healthwise, there are quite some concerns on its profitability. BLN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BLN had negative earnings in the past year.
In the past year BLN has reported a negative cash flow from operations.
BLN had negative earnings in each of the past 5 years.
BLN had negative operating cash flow in 4 of the past 5 years.
BLN.CA Yearly Net Income VS EBIT VS OCF VS FCFBLN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

The Return On Assets of BLN (-4.50%) is better than 61.54% of its industry peers.
BLN has a better Return On Equity (-9.16%) than 69.23% of its industry peers.
Industry RankSector Rank
ROA -4.5%
ROE -9.16%
ROIC N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
BLN.CA Yearly ROA, ROE, ROICBLN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

With an excellent Gross Margin value of 60.67%, BLN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
BLN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
BLN.CA Yearly Profit, Operating, Gross MarginsBLN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

BLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLN has been increased compared to 1 year ago.
Compared to 5 years ago, BLN has more shares outstanding
BLN has a better debt/assets ratio than last year.
BLN.CA Yearly Shares OutstandingBLN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BLN.CA Yearly Total Debt VS Total AssetsBLN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

BLN has an Altman-Z score of 4.00. This indicates that BLN is financially healthy and has little risk of bankruptcy at the moment.
BLN has a Altman-Z score of 4.00. This is comparable to the rest of the industry: BLN outperforms 53.85% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that BLN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.15, BLN perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 4
ROIC/WACCN/A
WACC7.72%
BLN.CA Yearly LT Debt VS Equity VS FCFBLN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

BLN has a Current Ratio of 2.35. This indicates that BLN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BLN (2.35) is better than 69.23% of its industry peers.
A Quick Ratio of 2.02 indicates that BLN has no problem at all paying its short term obligations.
The Quick ratio of BLN (2.02) is better than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.02
BLN.CA Yearly Current Assets VS Current LiabilitesBLN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.43% over the past year.
The Revenue has grown by 26.80% in the past year. This is a very strong growth!
The Revenue has been growing by 30.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)51.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.67%
Revenue 1Y (TTM)26.8%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%13.81%

3.2 Future

Based on estimates for the next years, BLN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.75% on average per year.
Based on estimates for the next years, BLN will show a very strong growth in Revenue. The Revenue will grow by 22.18% on average per year.
EPS Next Y61.38%
EPS Next 2Y51.23%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue Next Year23.82%
Revenue Next 2Y23.01%
Revenue Next 3Y29.63%
Revenue Next 5Y22.18%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLN.CA Yearly Revenue VS EstimatesBLN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
BLN.CA Yearly EPS VS EstimatesBLN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 145.66, the valuation of BLN can be described as expensive.
Based on the Price/Forward Earnings ratio, BLN is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.90. BLN is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 145.66
BLN.CA Price Earnings VS Forward Price EarningsBLN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

BLN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 389.95
BLN.CA Per share dataBLN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BLN's earnings are expected to grow with 20.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.23%
EPS Next 3Y20.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACKLINE SAFETY CORP

TSX:BLN (7/4/2025, 7:00:00 PM)

7.11

-0.03 (-0.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)06-11 2025-06-11
Earnings (Next)09-09 2025-09-09
Inst Owners25.71%
Inst Owner ChangeN/A
Ins Owners2.87%
Ins Owner ChangeN/A
Market Cap616.15M
Analysts80
Price Target9.33 (31.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.92%
Min Revenue beat(2)-6.13%
Max Revenue beat(2)13.97%
Revenue beat(4)2
Avg Revenue beat(4)1.47%
Min Revenue beat(4)-6.38%
Max Revenue beat(4)13.97%
Revenue beat(8)3
Avg Revenue beat(8)-0.01%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)3.23%
PT rev (3m)3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 145.66
P/S 4.31
P/FCF N/A
P/OCF N/A
P/B 7.66
P/tB 8.33
EV/EBITDA 389.95
EPS(TTM)-0.17
EYN/A
EPS(NY)0.05
Fwd EY0.69%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.65
BVpS0.93
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.5%
ROE -9.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.67%
FCFM N/A
ROA(3y)-27.21%
ROA(5y)-24.23%
ROE(3y)-67.04%
ROE(5y)-51.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.27%
GM growth 5Y4.6%
F-Score5
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 8.37
Cap/Depr 102.31%
Cap/Sales 6.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.02
Altman-Z 4
F-Score5
WACC7.72%
ROIC/WACCN/A
Cap/Depr(3y)111.77%
Cap/Depr(5y)105.56%
Cap/Sales(3y)8.6%
Cap/Sales(5y)9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.67%
EPS Next Y61.38%
EPS Next 2Y51.23%
EPS Next 3Y20.71%
EPS Next 5Y25.75%
Revenue 1Y (TTM)26.8%
Revenue growth 3Y32.83%
Revenue growth 5Y30.78%
Sales Q2Q%13.81%
Revenue Next Year23.82%
Revenue Next 2Y23.01%
Revenue Next 3Y29.63%
Revenue Next 5Y22.18%
EBIT growth 1Y64.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.57%
EBIT Next 3Y65.48%
EBIT Next 5Y41.81%
FCF growth 1Y82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y96.97%
OCF growth 3YN/A
OCF growth 5YN/A